²é¿´: 198  |  »Ø¸´: 0

CIMR

гæ (³õÈëÎÄ̳)

[½»Á÷] ´´ÐÂÖÐÐÄÓÈÖÒʤʵÑéÊÒÕÐÆ¸²©Ê¿ºó

¾ßÌ幤×÷µØµã:
±±¾©ÊзáÌ¨ÇøÓÒ°²ÃÅÍâÎ÷Í·Ìõ10ºÅ
н½ð:
н×ÊÃæÒé
ÕÐÆ¸¸Úλ:
²©Ê¿ºó
¹«Ë¾Ãû³Æ:
Ê×¶¼Ò½Ñ§¿ÆÑ§´´ÐÂÖÐÐÄ
¹«Ë¾ÍøÖ·:
www.cimrbj.ac.cn

Ò»¡¢´´ÐÂÖÐÐļò½é
Ê×¶¼Ò½Ñ§¿ÆÑ§´´ÐÂÖÐÐÄ[chinese institutes for medical research (cimr), beijing]£¨¼ò³Æ´´ÐÂÖÐÐÄ£©ÊDZ±¾©ÊÐгÉÁ¢µÄ¾ßÓжÀÁ¢·¨ÈË×ʸñµÄÐÂÐÍÑз¢»ú¹¹¡£´´ÐÂÖÐÐÄÒÔÍÆ¶¯Ò½Ñ§¿ÆÑ§·¢Õ¹¡¢¸ÄÉÆÈËÀཡ¿µÎªÄ¿±ê£¬¿ªÕ¹ÉúÎïҽѧÑо¿£¬ÖÂÁ¦ÓÚÌáÉýҽѧ¿ÆÑ§´´ÐÂÓë³É¹ûת»¯ÄÜÁ¦£¬Ìá¸ß¼²²¡Õï¶ÏºÍÖÎÁÆË®Æ½¡£ÎÒÃǽ«»ã¾ÛÊÀ½ç¸ßˮƽ¿ÆÑ§¼Ò£¬ÓëÊ×¶¼Ò½Ñ§½ÌÓýºÍ¿ÆÑ§Ñо¿ÓÅÖÊ×ÊÔ´½ôÃܺÏ×÷£¬´òÔì¶àѧ¿Æ½»²æÈںϵĿÆÑÐÆ½Ì¨£¬×ÛºÏ×ÔÓÉ̽Ë÷¡¢Ò½Ñ§Ä¿±êµ¼Ïò¡¢ÓÐ×éÖ¯¿ÆÑеÈ;¾¶£¬Êµ¼ùÐÂÐÍ¿ÆÑÐģʽºÍÌåÖÆ»úÖÆ£¬ÅàÑøÊÊӦҽѧ¿ÆÑ§´´Ð·¢Õ¹µÄÓÅÐãÈ˲ţ¬Öð²½ÍƽøÒ½½ÌÑвúµÄÉî¶ÈÈںϣ¬ÖúÁ¦Ê×¶¼Ò½¿Æ´óѧ³ÉΪÊÀ½çÒ»Á÷µÄÒ½¿Æ´óѧ¡£

¶þ¡¢ÊµÑéÊÒ½éÉÜ
ÓÈÖÒʤ½ÌÊÚ·Ö±ðÔÚÕã½­´óѧ£¬ÖпÆÔºÉϺ£Éú»¯Ëù¡¢ÃÀ¹ú¼ÓÖÝ´óѧʥµØÑǸç·ÖУ£¨university of california, san diego£©ÉúÎïϵȡµÃѧʿ¡¢Ë¶Ê¿¡¢²©Ê¿Ñ§Î»£¬ÔÚË÷¶û¿ËÉúÎïÑо¿Ëù£¨salk institute£©´Óʲ©Ê¿ºóÑо¿¡£2009Äê³ÉΪÃÀ¹úʥ·Ò×˹»ªÊ¢¶Ù´óѧҽѧԺ£¨washington university in st. louis , school of medicine, washu medicine)ϸ°ûÉúÎïѧÓëÉúÀíѧϵÖúÀí½ÌÊÚ£¬2023Äê½úÉýΪÕý½ÌÊÚ¡£ÓÈÖÒʤʵÑéÊÒÖ÷ÒªÑо¿Ï¸°û»ùÒò×éά³Ö¡¢rnaÖÊÁ¿¼à²âÒÔ¼°ÏÈÌìÃâÒß»úÖÆ£¬ ¿ª·¢Õë¶ÔÖ×Áö¡¢×ÔÉíÃâÒߵȼ²²¡µÄÐÂÐÍÖÎÁƲßÂÔºÍÒ©Îï¡£ÔÚnature medicine, molecular cell, nature cell biologyµÈ¿¯Îï·¢±í¶àƪ¸ßˮƽÂÛÎÄ£¬±¨µÀÔ­´´ÐÔ·¢ÏÖ¡£±¾ÊµÑéÊÒΪ²»Í¬Ñ§Êõ±³¾°µÄÑо¿ÕßÌṩ¿ª·ÅµÄƽ̨£¬³ÏÑûÓÐ־֮ʿÓëÎÒÃǹ²¸°Ì½Ë÷¡¢´´ÐÂÖ®Âá£ÓÈÖÒʤ½ÌÊÚ¾ßÓзḻµÄѧÉúºÍ²©ºóÅàÑø¾­Ñé£¬ÔøÈÎwashu·Ö×Óϸ°û²©Ê¿ÉúÅàÑøÏîÄ¿£¨mcb graduate program£©ÁªºÏÖ÷ÈΡ¢ÉúÎïÓëÉúÎïҽѧ²¿(division of biology and biomedical sciences)Ö´ÐÐίԱ»áίԱ¡£

ʵÑéÊÒÍøÕ¾£º
https://www.cimrbj.ac.cn/channel/1972162189498388480.html

ʵÑéÊÒÑо¿·½Ïò
1. »ùÒò×éÎȶ¨ÐÔ¡¢rnaÖÊÁ¿¼à²âȱÏÝÓëÏÈÌìÃâÒßϵͳµÄÏ໥×÷ÓÃ
2. Àë×ÓºÍÀë×ÓͨµÀµ°°×ÔÚcgas/sting½éµ¼µÄÏÈÌìÃâÒß·´Ó¦Öеĵ÷¿Ø×÷ÓÃ
3. °ÐÏòtrpv2-sting»¥×÷£¬¿ª·¢ÓÃÓÚÖ×ÁöÓë×ÔÉíÃâÒß¼²²¡µÄ¾«×¼ÖÎÁƲßÂÔ
4. ¼ô½ÓÌåÍ»±äÏà¹ØÖ×ÁöÖеÄnmdͨ·ʧµ÷Óë°ÐÏòÖÎÁÆÇ°¾°

½üÆÚÖ÷ÒªÑо¿³É¹û
1.ȫлùÒò×é±£»¤ÐźÅͨ·£º·¢ÏÖ²¢½âÎöÒ»ÌõÓɰûÖÊdna¼¤»î¡¢ ca²⁺½éµ¼µÄ¸´ÖƲ汣»¤Í¨Â·£¬¼ø¶¨ÁË 10 Óà¸öºËÐĵ÷¿ØÒò×Ó(li et al., mol cell 2019; li et al., mol cell 2023; kong et al., nat commun 2024)
2.trpv2-sting»¥×÷: Ê״η¢ÏÖstingÓë¸ÆÀë×ÓͨµÀµ°°×trpv2ÔÚÄÚÖÊÍøÉϵÄÏ໥×÷Ó㬸û¥×÷µ÷¿ØÏ¸°ûÄÚ¸ÆÀë×Óˮƽ£¬²¢¿ØÖÆcgas/stingÏÈÌìÃâÒßϵͳµÄ¾²Ï¢Ó뼤»î£¨li et al., mol cell 2023; cheng et al., cell rep, accepted£©
3.ÎÞÒå rna ½µ½âµ÷¿ØÓëÖ×ÁöÖÎÁÆ£º¹¹½¨¶à¸ö nmd ±¨¸æÏµÍ³£¬ÓÃÓÚ¸ßͨÁ¿Ò©ÎïɸѡÓëÈ«»ùÒò×é crispr ÒÅ´«É¸Ñ¡£¬¼ø¶¨¶à¸ö nmd ÒÖÖÆ¼Á¼°µ÷¿ØÒò×Ó£»½Òʾ nmd ÊÇЯ´ø¼ô½ÓÌåÍ»±äµÄѪҺÖ×ÁöµÄDZÔÚÖÎÁưеã (nickless et al., nat med 2014; nickless et al., jbc 2017; cheruiyot et al., cancer res 2021)
´ú±íÐÔÎÄÕ£º
nature communications, 2024, doi: 10.1038/s41467-024-48988-6. pmid: 38816425.
molecular cell, 2023, doi: 10.1016/j.molcel.2022.12.034. pmid: 36696898.
molecular cell, 2019, doi: 10.1016/j.molcel.2019.04.003. pmid: 31053472.
cancer research, 2021, doi: 10.1158/0008-5472.can-20-4016. pmid: 34215620.
nature medicine, 2014, doi: 10.1038/nm.3620. pmid: 25064126

Èý¡¢ÕÐÆ¸¸Úλ
²©Ê¿ºó 2-3Ãû
1.Ö÷ÒªÖ°Ôð
£¨1£©ÔÚpiÖ¸µ¼Ï¶ÀÁ¢¿ªÕ¹Ñо¿¹¤×÷£»
£¨2£©Ð­ÖúÖ¸µ¼Ñо¿ÉúÒÔ¼°×«Ð´ÂÛÎĺͻù½ðÉêÇë¡£

2.ÈÎÖ°ÒªÇó
£¨1£©ÒÑ»ñµÃ»ò¼´½«»ñµÃ²©Ê¿Ñ§Î»£¬¾ßÓÐϸ°ûÉúÎïѧ¡¢½á¹¹ÉúÎïѧ¡¢ÉúÎïÐÅϢѧ»òÆäËûÏà¹ØÁìÓòµÄÑо¿±³¾°£»
£¨2£©ÒÔµÚÒ»×÷ÕßÉí·ÝÔÚÁìÓòÄÚÖ÷Á÷ÆÚ¿¯ÉÏ·¢±í¹ý»ò¼´½«·¢±íÑо¿ÂÛÎÄ£»
£¨3£©¾ß±¸¶ÀÁ¢¿ªÕ¹¿ÆÑй¤×÷ÄÜÁ¦£»
£¨4£©¾ßÓиßÕǵĿÆÑÐÈÈÇé¡¢ÑϽ÷µÄ¿ÆÑÐ̬¶È¡¢Á¼ºÃµÄ¹µÍ¨ÄÜÁ¦ºÍÍŶӺÏ×÷¾«Éñ£»
£¨5£©¾ß±¸Á¼ºÃµÄÓ¢Óï¶ÁдºÍÈÕ³£½»Á÷ÄÜÁ¦£¬Äܹ»Ê¹ÓÃÓ¢ÎÄ׫дÂÛÎÄ¡£

ËÄ¡¢¸£Àû´ýÓö
1. ¸ù¾ÝӦƸÕߵŤ×÷¾­ÑéºÍÄÜÁ¦£¬Ìṩ¾ßÓÐÊг¡¾ºÕùÁ¦µÄн³ê£¨ÏêÇéÃæÌ¸£©£»
2.ÏíÊÜÎåÏÕÒ»½ð¡¢´øÐ½Äê¼Ù¡¢Ìå¼ìºÍ²¹³äÒ½ÁƱ£Ïյȣ»
3.Ö§³Ö¸öÈËÖ°Òµ·¢Õ¹£¬Ìṩ±ØÒªµÄ¹¤×÷Ïà¹Ø×¨ÒµÅàѵ¡£

Îå¡¢ÉêÇë·½·¨
ӦƸÕßÇ뽫¸öÈ˼òÀú¡¢Ñо¿ÐËȤ»ò¼Æ»®£¬2-3ÃûÍÆ¼öÈ˵ÄÐÕÃû¼°ÁªÏµ·½Ê½£¬ÒÔ¼°ÆäËûÄÜÖ¤Ã÷¿ÆÑÐÄÜÁ¦µÄÏà¹Øµç×ÓÎļþ·¢Ë͵½ÓÊÏäzyou@cimrbj.ac.cn£¬ÓʼþÖ÷ÌâÇë×¢Ã÷¡°Ó¦Æ¸ÕßÃû×Ö+¾ßÌåӦƸְλ¡±¡£

ÁªÏµÈË£ºÓȽÌÊÚ

ÁªÏµµØÖ·£º±±¾©ÊзáÌ¨ÇøÓÒ°²ÃÅÍâÎ÷Í·Ìõ10ºÅ-Ê×¶¼Ò½Ñ§¿ÆÑ§´´ÐÂÖÐÐÄ
±¾ÕÐÆ¸³¤ÆÚÓÐЧ£¬ÖÁÕÐÆ¸µ½ºÏÊÊÈËѡΪֹ¡£

[ À´×Ô°æ¿éȺ ±±¾© ]

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ CIMR µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 268Çóµ÷¼Á +3 ¼òµ¥µã0 2026-03-17 3/150 2026-03-17 23:15 by wangjihu
[¿¼ÑÐ] 070300»¯Ñ§319Çóµ÷¼Á +4 ½õÀð0909 2026-03-17 4/200 2026-03-17 18:21 by ÖØ¿ÆÐ¡°ÔÍõ
[¿¼ÑÐ] 344Çóµ÷¼Á +4 knight344 2026-03-16 4/200 2026-03-17 17:27 by ruiyingmiao
[¿¼ÑÐ] 0854¿É¿çµ÷¼Á£¬Ò»×÷Ò»ÏîºËÐÄÂÛÎÄÎåÏîרÀû£¬Ê¡¡¢¹ú¼¶Ö¤Êé40+ÊýÒ»Ó¢Ò»287 +3 СÀî0854 2026-03-16 3/150 2026-03-17 13:40 by ÈÈÇéɳĮ
[¿¼ÑÐ] 302Çóµ÷¼Á +4 С¼Öͬѧ123 2026-03-15 8/400 2026-03-17 10:33 by С¼Öͬѧ123
[¿¼ÑÐ] ¶«ÄÏ´óѧ364Çóµ÷¼Á +5 JasonYuiui 2026-03-15 5/250 2026-03-16 21:28 by ľ¹Ï¸à
[¿¼ÑÐ] Ò»Ö¾Ô¸985£¬±¾¿Æ211£¬0817»¯Ñ§¹¤³ÌÓë¼¼Êõ319Çóµ÷¼Á +5 Liwangman 2026-03-15 5/250 2026-03-16 17:10 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] 311Çóµ÷¼Á +5 26ÑÐ0 2026-03-15 5/250 2026-03-16 16:21 by a²»Ò×
[¿¼ÑÐ] 0703 ÎïÀí»¯Ñ§µ÷¼Á +3 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-13 5/250 2026-03-16 10:50 by ÎÒ¿ÉÒÔÉϰ¶µÄ¶ÔÂ
[½Ìʦ֮¼Ò] ½¹ÂÇ +7 Ë®±ùÔÂÔÂÒ°Íà 2026-03-13 9/450 2026-03-16 10:00 by Quakerbird
[¿¼ÑÐ] 327Çóµ÷¼Á +6 ʰ¹âÈÎȾ 2026-03-15 11/550 2026-03-15 22:47 by ʰ¹âÈÎȾ
[¿¼ÑÐ] 26¿¼ÑÐÒ»Ö¾Ô¸ÖйúʯÓÍ´óѧ(»ª¶«)305·ÖÇóµ÷¼Á +3 ¼ÎÄêÐÂ³Ì 2026-03-15 3/150 2026-03-15 13:58 by ¹þ¹þ¹þ¹þºÙºÙºÙ
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¹¤´ó²ÄÁÏ324·ÖÇóµ÷¼Á +5 ãÆÐñ¶« 2026-03-14 5/250 2026-03-14 14:53 by ľ¹Ï¸à
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-03-13 4/200 2026-03-14 08:37 by zhukairuo
[¿¼ÑÐ] 308Çóµ÷¼Á +5 ÊÇLupa°¡ 2026-03-11 5/250 2026-03-13 22:13 by JourneyLucky
[¿¼ÑÐ] Çóµ÷¼Á£¨²ÄÁÏÓ뻯¹¤327£© +4 °®³ÔÏã²ËÀ² 2026-03-11 4/200 2026-03-13 22:11 by JourneyLucky
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤085600µ÷¼ÁÇóÀÏʦÊÕÁô +9 jiaanl 2026-03-11 9/450 2026-03-13 20:22 by JourneyLucky
[¿¼ÑÐ] ÍÁľµÚÒ»Ö¾Ô¸276Çóµ÷¼Á£¬¿ÆÑкͼ¼ÄÜÊ®·Ö·á¸»£¬ÇóÐÂÐË·½ÏòµÄµ¼Ê¦ÊÕÁô +3 ÍÁľСÌì²Å 2026-03-12 3/150 2026-03-13 15:01 by JourneyLucky
[ÂÛÎÄͶ¸å] Ͷ¸åÎÊÌâ 5+4 Ðǹâ²ÓÀÃxt 2026-03-12 6/300 2026-03-13 14:17 by god_tian
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +3 ´Þwj 2026-03-12 4/200 2026-03-12 19:33 by Çóµ÷¼Ázz
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û